DWA
NVO

Dorsey Wright & Associates’s Novo Nordisk NVO Stock Holding History

Dorsey Wright & Associates’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-62,128
Closed -$7.4M – 140
2024
Q3 		$7.4M Buy
62,128
+7,543
+14% +$1.01M 1.75% 9
2024
Q2 		$7.79M Sell
54,585
-1,850
-3% -$245K 2.02% 4
2024
Q1 		$7.25M Sell
56,435
-3,334
-6% -$397K 1.89% 6
2023
Q4 		$6.18M Sell
59,769
-4,644
-7% -$459K 1.88% 5
2023
Q3 		$5.86M Sell
64,413
-4,139
-6% -$365K 1.82% 6
2023
Q2 		$5.55M Sell
68,552
-6,888
-9% -$563K 1.67% 8
2023
Q1 		$6M Sell
75,440
-5,024
-6% -$356K 1.82% 5
2022
Q4 		$5.44M Buy
+80,464
New +$4.72M 1.59% 8
2022
Q2 		$4.98M Sell
89,412
-10,636
-11% -$590K 1.46% 14
2022
Q1 		$5.55M Sell
100,048
-3,006
-3% -$154K 1.29% 16
2021
Q4 		$5.77M Buy
103,054
+2,026
+2% +$110K 1.19% 23
2021
Q3 		$4.85M Buy
+101,028
New +$4.88M 1.06% 31
2021
Q1 		– Sell
-118,638
Closed -$4.14M – 346
2020
Q4 		$4.14M Sell
118,638
-1,642
-1% -$56.8K 0.61% 37
2020
Q3 		$4.17M Buy
120,280
+1,732
+1% +$57.7K 0.75% 33
2020
Q2 		$3.89M Sell
118,548
-9,730
-8% -$310K 0.79% 28
2020
Q1 		$3.86M Buy
128,278
+35,878
+39% +$1.07M 1.46% 17
2019
Q4 		$2.67M Buy
+92,400
New +$2.56M 0.88% 41
2013
Q3 		– Sell
-8,940
Closed -$139K – 121
2013
Q2 		$139K Buy
+8,940
New +$149K 0.02% 86

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Dorsey Wright & Associates's NVO Position: Q4 2024 in Review

Dorsey Wright & Associates sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 62,128 shares — an estimated $7.4M sold.

Dorsey Wright & Associates first reported a position in NVO in Q2 2013 and held it in 18 quarters. The position peaked at $7.79M in Q2 2024. 1,665 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Dorsey Wright & Associates reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Dorsey Wright & Associates sold 62,128 Novo Nordisk shares in Q4 2024, an estimated $7.4M.
  • Dorsey Wright & Associates first reported a position in Novo Nordisk in Q2 2013 and held it in 18 quarters.
  • Dorsey Wright & Associates's Novo Nordisk position peaked at $7.79M in Q2 2024.
  • 1,665 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Dorsey Wright & Associates's 13F filing for Q4 2024, filed 12 Feb 2025.